Rapid Micro Biosystems (RPID) Liabilities and Shareholders Equity (2020 - 2026)

Rapid Micro Biosystems (RPID) has 7 years of Liabilities and Shareholders Equity data on file, last reported at $62.4 million in Q1 2026.

• For the quarter ending Q1 2026, Liabilities and Shareholders Equity fell 27.0% year-over-year to $62.4 million; the trailing twelve-month figure through Mar 2026 stood at $297.2 million (down 26.89% YoY), and the FY2025 full-year result was $74.9 million, down 23.75% from the prior year.
• Liabilities and Shareholders Equity eased to $62.4 million in Q1 2026, from $74.9 million in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $230.1 million in Q1 2022 to a low of $62.4 million in Q1 2026.
• A 5-year average of $135.2 million and a median of $127.7 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
• Across the five-year window, Liabilities and Shareholders Equity surged 67.24% in 2022 and plunged 35.44% in 2025, its largest moves.
• Tracing RPID's Liabilities and Shareholders Equity over 5 years: stood at $190.6 million in 2022, then fell by 24.76% to $143.5 million in 2023, then sank by 31.57% to $98.2 million in 2024, then retreated by 23.75% to $74.9 million in 2025, then decreased by 16.68% to $62.4 million in 2026.
• Business Quant data shows RPID's Liabilities and Shareholders Equity at $62.4 million in Q1 2026, $74.9 million in Q4 2025, and $84.4 million in Q3 2025.